Community PR for TB Elimination in Indonesia 2021-2023

Description

The global commitment to end tuberculosis (TB) is outlined in the End TB Strategy that targets a reduction in tuberculosis deaths by up to 90% in 2030 compared to 2015, a reduction in the incidence of tuberculosis by 80% in 2035 compared to 2015, and no household experiences catastrophic costs due to TB in 2030. In the End TB Strategy, it is emphasized that the target is expected to be achieved with innovation, such as developing vaccines and new TB drugs with short-term regiments.

The Ministry of Health of the Republic of Indonesia developed a roadmap for tuberculosis elimination in Indonesia for 2020-2030, which included a target to reduce tuberculosis incidence to 65 cases per 100,000 population by 2030. The target towards the achievement of the early stage of tuberculosis elimination in Indonesia by 2030 is optimized by tuberculosis epidemiological modeling using the Tuberculosis Impact Model and Estimates (TIME) device.

The Global Fund grant funding in the 2021-2023 period, which includes the matching fund on finding missing people with TB. Comunity Consortium Penabulu STPI as Principal Recipient will be used the grant funding to support the National TB Program in 30 provinces and 190 districts.

Continuing from the previous CSO grant, the PB-STPI Consortium will support cadres conducting contact investigation and organizing TB outreach at community level as well as treatment adherence for DS TB, case managers and patients supporters providing treatment adherence support for MDR-TB patients. It will also work on advocacy and addressing TB/HIV co-infection issues.

Through Matching Fund support, The PB-STPI Consortium in coordination with the National TB Program (including PHO, DHO) will support cadres (for DS-TB) and patient supporters (DR-TB) to conduct contact investigation, treatment adherence for patients in private sector following the District Public-Private Mix Strategy. In addition, particularly for DR-TB, patients supporters will work to find Loss-To-Follow-Up patients routinely to bring them back to treatment.

In the 2021-2023 period, community-based TB care delivery for both DS and MDR-TB will be complemented with efforts to overcome social and structural barriers such as stigma and discrimination, human rights violations and gender inequities at the workplace and at home.

In the 2021-2023 period, PB-STPI Consortium will also support community system strengthening activities and advocacy for local financing for sustainable TB care delivery.

Funding

This program is supported by The Global Fund based document Agreement IND-T-PBSTPI No. 1947 with total funding support of USD 48,741,713